Joseph W. LaPlume - Nov 9, 2023 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
EVP, Corp Strategy & Develop
Signature
/s/ Joseph W. LaPlume
Stock symbol
CRL
Transactions as of
Nov 9, 2023
Transactions value $
-$262,974
Form type
4
Date filed
11/13/2023, 04:12 PM
Previous filing
Aug 14, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Options Exercise $1.32M +9.13K +36.54% $144.67 34.1K Nov 9, 2023 Direct
transaction CRL Common Stock Sale -$447K -2.59K -7.58% $172.77 31.5K Nov 9, 2023 Direct F1
transaction CRL Common Stock Sale -$1.14M -6.54K -20.75% $173.76 25K Nov 9, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Options Exercise $0 -9.13K -100% $0.00* 0 Nov 9, 2023 Common Stock 9.13K $144.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $172.32 to $173.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $173.74 to $174.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.